The company has been exploring for years now. Who are they, Indiana Jones? I'd say if there was any interest at all they would take even a bad deal for either drug before doing a reverse split. I listed specific reasons why no partnership is forthcoming for any of these drugs, but the ultimate proof is the reverse split. Literally anything else would be a better option, but here we are. There is no partnership because there is nothing worth partnering.
So, in other words, crap you made up. This is a nonsense idea without any evidence. That registration statement provides exactly zero dollars of shareholder equity. They need to raise enough money to have $2.5 million in the bank at all times on top of their operating expenses. Last time $4.8M was not enough to do the job. Look for a $5-6M financing just for next quarter. With SP in low 30's, that is at least 40% dilution in the next few weeks with more to come in the next few months.